The CC Chemokine Receptor 4 as a Novel Specific Molecular Target for Immunotherapy in Adult T-Cell Leukemia/Lymphoma-Reference-Cited by-同舟云学术

The CC Chemokine Receptor 4 as a Novel Specific Molecular Target for Immunotherapy in Adult T-Cell Leukemia/Lymphoma

Published:2004-11-15 Issue:22 Volume:10 Page:7529-7539
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Ishida Takashi,Iida Shinsuke,Akatsuka Yoshiki,Ishii Toshihiko,Miyazaki Mikinori,Komatsu Hirokazu,Inagaki Hiroshi,Okada Noriko,Fujita Teizo,Shitara Kenya,Akinaga Shiro,Takahashi Toshitada,Utsunomiya Atae,Ueda Ryuzo

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the CCL17/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course;Cytokine;2024-10

2. Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations;Frontiers in Immunology;2024-09-03

3. Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity;Scientific Reports;2024-05-31

4. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified;Journal of Pathology and Translational Medicine;2024-03-15

5. Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor;Bioengineered;2024-01-07